Isolation and characterization of a novel rat factor H-related protein that is up-regulated in glomeruli under complement attack

被引:18
作者
Ren, GH [1 ]
Doshi, M [1 ]
Hack, BK [1 ]
Alexander, JJ [1 ]
Quigg, RJ [1 ]
机构
[1] Univ Chicago, Nephrol Sect, Dept Med, Chicago, IL 60637 USA
关键词
D O I
10.1074/jbc.M205135200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The factor H family in humans is composed of seven distinct proteins, including factor H-related proteins (FHR) 1-5. All members contain tandemly arranged short consensus repeats (SCR) typical of the regulators of complement activation gene family. FHR-5 is unusual for this group of proteins, as it was initially identified as a component of immune deposits in glomerular diseases. During our cloning of the cDNA for rat factor H from glomerular epithelial cells (GEC), we identified an alternative 2729-bp cDNA transcript. The translated sequence encoded a protein containing 11 SCRs, most similar to SCRs 7-15 and 19-20 in native rat factor H, which is the same basic structure of human FHR-5. As such, this rat protein was termed FHR. Recombinant rat FHR produced in a eukaryotic expression system had a molecular mass of 78 kDa. In functional studies, recombinant FHR bound C3b and inhibited the complement alternative pathway in a dose-dependent fashion. Given the prominent expression of FHR-5 in human membranous nephropathy, a disease in which complement activation occurs in the vicinity of GEC, the expression of FHR in a rat model of this disease was evaluated. In both in vitro and in vivo models of complement activation on the GEC, FHR mRNA was up-regulated by a factor of 3-6-fold compared with controls in which complement could not be activated. Thus, we have identified a novel factor H family member in rats. This FHR protein is analogous to human FHR-5, both in structure and in potential involvement in glomerular immune complex diseases.
引用
收藏
页码:48351 / 48358
页数:8
相关论文
共 47 条
[41]  
SKERKA C, 1992, J IMMUNOL, V148, P3313
[42]   Interactions between human complement components factor H, factor I and C3b [J].
Soames, CJ ;
Sim, RB .
BIOCHEMICAL JOURNAL, 1997, 326 :553-561
[43]   CONTROL OF AMPLIFICATION CONVERTASE OF COMPLEMENT BY PLASMA-PROTEIN BETA-1H [J].
WEILER, JM ;
DAHA, MR ;
AUSTEN, KF ;
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3268-3272
[44]   MODULATION OF ALTERNATIVE COMPLEMENT PATHWAY BY BETA-1H GLOBULIN [J].
WHALEY, K ;
RUDDY, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (05) :1147-1163
[45]   MODULATION OF C3B HEMOLYTIC ACTIVITY BY A PLASMA-PROTEIN DISTINCT FROM C3B INACTIVATOR [J].
WHALEY, K ;
RUDDY, S .
SCIENCE, 1976, 193 (4257) :1011-1013
[46]   The factor H protein family [J].
Zipfel, PF ;
Jokiranta, TS ;
Hellwage, J ;
Koistinen, V ;
Meri, S .
IMMUNOPHARMACOLOGY, 1999, 42 (1-3) :53-60
[47]   Complement factor H: Physiology and pathophysiology [J].
Zipfel, PF .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (03) :191-199